Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-14-000895
Filing Date
2014-08-19
Accepted
2014-08-19 12:38:47
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 277239
2 EXHIBIT 10.7 ex10_7.htm EX-10.7 120607
3 EXHIBIT 10.8 ex10_8.htm EX-10.8 120286
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8622
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 8622
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 4000
  Complete submission text file 0001255294-14-000895.txt   3238591

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rcha-20140630.xml EX-101.INS 363835
8 XBRL SCHEMA FILE rcha-20140630.xsd EX-101.SCH 35621
9 XBRL CALCULATION FILE rcha-20140630_cal.xml EX-101.CAL 31433
10 XBRL DEFINITION FILE rcha-20140630_def.xml EX-101.DEF 92013
11 XBRL LABEL FILE rcha-20140630_lab.xml EX-101.LAB 174366
12 XBRL PRESENTATION FILE rcha-20140630_pre.xml EX-101.PRE 169018
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

EIN.: 463259117 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54767 | Film No.: 141051333
SIC: 3430 Heating Equip, Except Elec & Warm Air; & Plumbing Fixtures